Previous Article | Next Article 
Journal of Clinical Microbiology, December 1998, p. 3726-3727, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Evaluation of the Auxacolor System for Biochemical
Identification of Medically Important Yeasts
Donald C.
Sheppard,*
Edwige
deSouza,
Zubair
Hashmi,
Hugh G.
Robson, and
Pierre
René
Division of Microbiology, Royal Victoria
Hospital, McGill University, Montreal, Quebec, Canada
Received 7 July 1998/Returned for modification 6 August
1998/Accepted 22 September 1998
 |
ABSTRACT |
We compared the Auxacolor yeast identification system (Sanofi
Diagnostics Pasteur) with the API 20C Aux (bioMerieux-Vitek) using 105 isolates of medically important yeasts. The Auxacolor system provided
more rapid, accurate results and displayed less interobserver
variability than the API 20C Aux.
 |
TEXT |
There has been a marked increase in
the incidence of systemic fungal disease caused by pathogenic yeasts
(5). Further, the increasing role of non-Candida
albicans species, some of which are intrinsically or potentially
resistant to antifungal agents, has made rapid species-level
identification important for optimizing therapy of acutely ill patients
(3, 6). Conventional assimilation techniques for the
identification of pathogenic yeasts are slow and impractical for
routine use and have led to a reliance on commercial micromethod
systems. The API 20C Aux (API 20C), the most widely used of these
systems, has been shown to provide reliable, accurate identification of
most yeast species (4). Although the API 20C represents a
significant improvement over traditional identification techniques, it
requires 48 to 72 h of incubation before reading, and it can be
difficult to interpret (1, 4).
The Auxacolor system (AUX) is a commercial yeast identification kit
which uses colorimetric tests for conventional assimilation substrates,
actidione resistance, and phenoloxidase production. Preliminary
studies have demonstrated accuracy comparable with that of the API 20C
(1, 2) but have not evaluated the speed of
identification or interobserver reliability. Because these factors are
crucial in the evaluation of a new identification strategy for use in
the clinical microbiology laboratory, we undertook a comparison of the
AUX and the API 20C with respect to these criteria.
Methods.
One hundred five strains comprising 16 species of
yeast were examined (Table 1).
Sixty-eight specimens were sterile-site isolates obtained from
inpatients at the Royal Victoria Hospital, and the remaining 37 were
clinical isolates obtained from a reference collection at the
Laboratoire de Santé Publique du Québec. All isolates had
been identified by traditional assimilation, biochemical, and
morphology tests. Isolates were subcultured to Sabouraud dextrose plates, incubated at 30°C for 48 h, and inoculated into both
test systems. API 20C strips were inoculated according to the
manufacturer's instructions, incubated at 30°C, and scored by two
independent blinded observers at 24, 48, and 72 h. Final
identification was made with reference to the printed and telephone
databases. The AUX microwell plate was inoculated according to the
manufacturer's instructions by using 2 drops of the test strain
suspended in the medium supplied. This was then incubated at 30°C and
read in the same manner as the API 20C. Color changes were noted, and a
code was developed; this was compared to the manufacturer's database
in order to generate an identification. Since both the AUX and the API
20C require morphological examination to complete coding, for either
system we considered any identification that yielded the correct
organism and a group of others differentiated only by morphological
criteria to be a correct result. Rates of correct identification and of
interobserver agreement were calculated and compared by the chi-square
test. A kappa statistic was developed for each system to evaluate the
reliability of interpretation between the primary and secondary
observers.
Results.
Significantly more strains were identified by the AUX
than by the API 20C at 24, 48, and 72 h (Table 1). This effect was consistent across species with the exception of Candida
guilliermondii, for which the API 20C identified one of two
strains at 24 h compared with neither of two strains by the AUX.
At 48 h each system identified both isolates correctly. There were
nine errors in identification with the AUX (Table
2). Of these nine errors, four were
misidentifications and five strains were not identifiable by using the
manufacturer's database. While the AUX incorrectly identified two
isolates each of Candida tropicalis, Candida
famata, and Saccharomyces cerevisiae, only one of these
six was correctly identified by the API 20C. We found no single
reaction that was consistently inaccurate in these specimens.
Both observers noted that interpretation of the individual reactions
was more easily performed with the AUX. The rate of interobserver agreement was significantly higher with the AUX (294 of 315 interpretations) than with the API 20C (265 of 315 interpretations)
(kappa statistic, 0.82 versus 0.70; P < 0.01).
Discussion.
The ideal commercial identification system must be
cheap, be easy to use, provide rapid accurate results, and have high
interobserver reliability. The cost of the AUX is comparable to that of
the API 20C, growth requirements prior to inoculation are identical, and the inoculum preparation for the AUX is less complicated, with only
a single dilution.
The overall rate of correct identification of 91.4% found in this
study for the AUX was in line with previously documented rates of 98.3 and 85.7% (1, 2) and was superior to that of the API 20C.
This superiority was preserved in the species-by-species analysis with
the exception of Cryptococcus albidus (four of four isolates
correctly identified by the API 20C versus three of four with the AUX).
In particular, a marked superiority in the identification of
Candida lusitaniae, a species often misidentified by the API 20C and other systems (4), was noted.
Rapidity of identification was significantly higher with the AUX. This
was most true for C. albicans, Candida glabrata,
and Candida krusei; all strains of these three species were
identified by 24 h. This is of particular clinical relevance
because it allows for detection of the two most common azole-resistant
organisms within 24 h. A reduction of 24 to 48 h in
turnaround time for these organisms can be translated directly into a
more rapid transition from empirical to directed antifungal therapy.
There was a significant reduction in interobserver variability of
interpretation with the AUX, likely due to the advantage of reading
color changes rather than turbidity. In clinical practice, where
multiple technicians are often responsible for a given subspecialty bench on a rotating basis, this is useful in ensuring consistent interpretation and reporting of results.
While the traditional rapid-screening tests, such as germ tube and
rapid trehalose, remain the initial procedures of choice for
identification of clinical yeast specimens, many species are unidentifiable by these tests. Our findings suggest that the AUX may be
a useful tool for the biochemical identification of such isolates.
 |
ACKNOWLEDGMENTS |
We are indebted to Guy St.-Germain for providing some of the
strains used in this study and to Sanofi-Pasteur for donation of the
AUX test kits.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Microbiology
Royal Victoria Hospital, 687 Pine Ave. West
L5.06,
Montreal, Quebec, Canada H3A 1A1. Phone: (514) 842-1231, ext. 5065. Fax: (514) 844-7256. E-mail: dshepp{at}po-box.mcgill.ca.
 |
REFERENCES |
| 1.
|
Davey, K. G.,
P. M. Chant,
C. S. Downer,
C. K. Campbell, and D. W. Warnock.
1995.
Evaluation of the Auxacolor system, a new method of clinical yeast identification.
J. Clin. Pathol.
48:807-809[Abstract/Free Full Text].
|
| 2.
|
Hantschke, D.
1996.
Differentiation of yeast-like fungi using the commercial Auxacolor system.
Mycoses
39:135-140[Medline].
|
| 3.
|
Nguyen, M. H.,
J. E. Peacock,
A. J. Morris, et al.
1996.
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Am. J. Med.
100:617-623[Medline].
|
| 4.
|
St.-Germain, G., and D. Beauchesne.
1991.
Evaluation of the MicroScan Rapid Yeast Identification panel.
J. Clin. Microbiol.
29:2296-2299[Abstract/Free Full Text].
|
| 5.
|
Wade, J. C., and S. C. Schimpff.
1985.
Epidemiology and prevention of Candida infections, p. 111-133.
In
G. P. Bodey, and V. Fainstein (ed.), Candidiasis. Raven Press, New York, N.Y.
|
| 6.
|
Warren, N. G., and K. C. Hazen.
1995.
Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
Journal of Clinical Microbiology, December 1998, p. 3726-3727, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sheppard, D. C., René, P., Harris, A. D., Miller, M. A., Laverdière, M., deSouza, E., Robson, H. G.
(1999). Simple Strategy for Direct Identification of Medically Important Yeast Species from Positive Blood Culture Vials. J. Clin. Microbiol.
37: 2040-2041
[Abstract]
[Full Text]